Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertension

40 elderly patients with a diagnosis of acute myocardial infarction developed on the background of arterial hypertension were examined. The patients were divided into two groups: the main – 20 patients (18 men, 2 women), age 70.0 ± 1.8 years, and the control group – 20 patients (19 men, 1 woman), ag...

Full description

Saved in:
Bibliographic Details
Main Authors: Dotsenko N.J., Boev S.S., Shekhunova I.A.
Format: Article
Language:English
Published: Dnipro State Medical University 2013-03-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://medpers.dsma.dp.ua/issues/2013/N1/74-80.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850058953392652288
author Dotsenko N.J.
Boev S.S.
Shekhunova I.A.
author_facet Dotsenko N.J.
Boev S.S.
Shekhunova I.A.
author_sort Dotsenko N.J.
collection DOAJ
description 40 elderly patients with a diagnosis of acute myocardial infarction developed on the background of arterial hypertension were examined. The patients were divided into two groups: the main – 20 patients (18 men, 2 women), age 70.0 ± 1.8 years, and the control group – 20 patients (19 men, 1 woman), age 69.5 ± 1.6 years, who received the standard treatment of acute myocardial infarction and hypertension. "Standard therapy" included acetylsalicylic acid and clopidogrel, statins, beta-blockers and ACE inhi¬bitors, if necessary, drugs to control hypertension, according to the recom¬mendations of the Ukrainian Society of Cardiologists. In addition, the first group of patients undergoing standard therapy of AMI and hypertension was administered Vazonat® for 15 days intravenously at a dose of 1000 mg per day. Effect of Vazonat® (meldonium) therapy on the clinical and functional status, exercise capacity, and cognitive status in patients with acute myocardial infarction and hypertension against the background of dyscirculatory encephalopathy was studied explored. Psycho-emotional state of patients was studied by Beck's depression scale. Cognitive status was assessed by neuropsychological tests (Schulte tables, Luria’s test for memorizing of 10 words and Luria’s pictograms). In was shown dynamics a positive effects of Vazonat® therapy on the improvement of cardio¬hemo¬dynamics (noted reduction in LVED with 55.20 ± 1.7 mm to 51.28 ± 1.5 mm (p > 0.1), an increasing transmitral flow Ve/Va from 0.98 ± 0.03 to 1.10 ± 0.04 (p < 0.05)), an increasing exercise tolerance (at 6MWT distance increased by 12.8% in the main group (from 289.6 ± 12.2 m to 326.0 ± 13.5 m)), an increasing the speed of active attention – time of sensorimotor reactions decreased from 68.55 ± 6.2 sec to 54.35 ± 3.52 sec (p < 0.05), increasing productivity of short-term memory, increasing the number of words in the Luria test from 5.90 ± 0.42 to 7.25 ± 0.38 (p < 0.05), moderate antidepressant effects and the ability to improve overall health in this group of patients compared with the control group. Good tolerance and safety of Vazonat® was proven. Studies presented show multiple propertics of the pharmacodynamics of Vazonat®. The unique properties of Vazonat® as a universal cytoprotector are the basis of its ability to improve outcomes after myocardial infarction in elderly persons after stabilization and selection of basic therapy.
format Article
id doaj-art-12d3f53ce5554357b72f338562f71dde
institution DOAJ
issn 2307-0404
2307-0404
language English
publishDate 2013-03-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-12d3f53ce5554357b72f338562f71dde2025-08-20T02:51:00ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042013-03-011817480Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertensionDotsenko N.J.0Boev S.S.1Shekhunova I.A. 2Zaporozhye Medical Academy of Postgraduate Education of Health Ministry of UkraineZaporozhye Medical Academy of Postgraduate Education of Health Ministry of UkraineZaporozhye Medical Academy of Postgraduate Education of Health Ministry of Ukraine40 elderly patients with a diagnosis of acute myocardial infarction developed on the background of arterial hypertension were examined. The patients were divided into two groups: the main – 20 patients (18 men, 2 women), age 70.0 ± 1.8 years, and the control group – 20 patients (19 men, 1 woman), age 69.5 ± 1.6 years, who received the standard treatment of acute myocardial infarction and hypertension. "Standard therapy" included acetylsalicylic acid and clopidogrel, statins, beta-blockers and ACE inhi¬bitors, if necessary, drugs to control hypertension, according to the recom¬mendations of the Ukrainian Society of Cardiologists. In addition, the first group of patients undergoing standard therapy of AMI and hypertension was administered Vazonat® for 15 days intravenously at a dose of 1000 mg per day. Effect of Vazonat® (meldonium) therapy on the clinical and functional status, exercise capacity, and cognitive status in patients with acute myocardial infarction and hypertension against the background of dyscirculatory encephalopathy was studied explored. Psycho-emotional state of patients was studied by Beck's depression scale. Cognitive status was assessed by neuropsychological tests (Schulte tables, Luria’s test for memorizing of 10 words and Luria’s pictograms). In was shown dynamics a positive effects of Vazonat® therapy on the improvement of cardio¬hemo¬dynamics (noted reduction in LVED with 55.20 ± 1.7 mm to 51.28 ± 1.5 mm (p > 0.1), an increasing transmitral flow Ve/Va from 0.98 ± 0.03 to 1.10 ± 0.04 (p < 0.05)), an increasing exercise tolerance (at 6MWT distance increased by 12.8% in the main group (from 289.6 ± 12.2 m to 326.0 ± 13.5 m)), an increasing the speed of active attention – time of sensorimotor reactions decreased from 68.55 ± 6.2 sec to 54.35 ± 3.52 sec (p < 0.05), increasing productivity of short-term memory, increasing the number of words in the Luria test from 5.90 ± 0.42 to 7.25 ± 0.38 (p < 0.05), moderate antidepressant effects and the ability to improve overall health in this group of patients compared with the control group. Good tolerance and safety of Vazonat® was proven. Studies presented show multiple propertics of the pharmacodynamics of Vazonat®. The unique properties of Vazonat® as a universal cytoprotector are the basis of its ability to improve outcomes after myocardial infarction in elderly persons after stabilization and selection of basic therapy.http://medpers.dsma.dp.ua/issues/2013/N1/74-80.pdfmyocardial infarctionarterial hypertensioncognitive disorderselderly age
spellingShingle Dotsenko N.J.
Boev S.S.
Shekhunova I.A.
Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertension
Medičnì Perspektivi
myocardial infarction
arterial hypertension
cognitive disorders
elderly age
title Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertension
title_full Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertension
title_fullStr Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertension
title_full_unstemmed Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertension
title_short Effects of meldonium on cognitive and clinico-functional status of elderly patients with acute myocardial infarction and arterial hypertension
title_sort effects of meldonium on cognitive and clinico functional status of elderly patients with acute myocardial infarction and arterial hypertension
topic myocardial infarction
arterial hypertension
cognitive disorders
elderly age
url http://medpers.dsma.dp.ua/issues/2013/N1/74-80.pdf
work_keys_str_mv AT dotsenkonj effectsofmeldoniumoncognitiveandclinicofunctionalstatusofelderlypatientswithacutemyocardialinfarctionandarterialhypertension
AT boevss effectsofmeldoniumoncognitiveandclinicofunctionalstatusofelderlypatientswithacutemyocardialinfarctionandarterialhypertension
AT shekhunovaia effectsofmeldoniumoncognitiveandclinicofunctionalstatusofelderlypatientswithacutemyocardialinfarctionandarterialhypertension